Previous close | 0.3500 |
Open | 0.3500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 65.00 |
Expiry date | 2024-08-16 |
Day's range | 0.3500 - 0.3500 |
Contract range | N/A |
Volume | |
Open interest | 20 |
On May 28, 2024, William Hoffman, Director at Inari Medical Inc (NASDAQ:NARI), executed a sale of 60,000 shares of the company.
Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of DirectorsBaruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of the Scientific Advisory BoardOculis established a CHF 50 million flexible loan facility with funds and accounts managed by BlackRock ZUG, Switzerland, May 30, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: O
Inari Medical (NARI) files a patent infringement lawsuit against Imperative Care and its subsidiary Truvic over intentionally copying and overlapping the designs of Inari Medical's products.